Redefining Treatment Across the Spectrum of HR+/HER2-Expressing Metastatic Breast Cancer

Join our live broadcast to redefine HR+/HER2-expressing mBC treatment via cutting-edge data on ADCs, sequencing therapies, and AE management strategies.